Search Results - "Diehl, Anna M"

Refine Results
  1. 1

    Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis by Diehl, Anna M, Day, Christopher

    Published in The New England journal of medicine (23-11-2017)
    “…Nonalcoholic steatohepatitis is a major cause of cirrhosis and liver cancer. It is associated with visceral adiposity and the metabolic syndrome and is nearly…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4
  5. 5

    Overexpression of caspase-3 in hepatocellular carcinomas by Persad, Rajendra, Liu, Chen, Wu, Tsung-Teh, Houlihan, Patrick S, Hamilton, Stanley R, Diehl, Anna M, Rashid, Asif

    Published in Modern pathology (01-07-2004)
    “…Caspase-3 is a downstream effector cysteine protease in the apoptotic pathway. It is ubiquitously expressed in normal human tissues including the liver…”
    Get full text
    Journal Article
  6. 6

    Implication of gut microbiota in nonalcoholic fatty liver disease by Boursier, Jerome, Diehl, Anna Mae

    Published in PLoS pathogens (01-01-2015)
    “…It is now well established that gut flora and chronic liver diseases are closely interrelated. This association is most evident at late stages of the disease:…”
    Get full text
    Journal Article
  7. 7

    Nonalcoholic Steatohepatitis by Yildiz, Halil, Ashrafian, Hutan, Sachak, Taha, Yearsley, Martha, Levin, Douglas, Rahmoune, Hakim, Boutrid, Nada, Bioud, Belkacem, Diehl, Anna M, Day, Christopher

    Published in The New England journal of medicine (22-02-2018)
    “…To the Editor: In the review article by Diehl and Day (Nov. 23 issue), 1 about the cause, pathogenesis, and treatment of nonalcoholic steatohepatitis, the…”
    Get full text
    Journal Article
  8. 8

    Nonalcoholic steatosis and steatohepatitis IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines by Diehl, Anna Mae

    “…Macrophage products, such as cytokines, prostanoids, nitric oxide, and reactive oxygen intermediates, influence the function and viability of macrophages and…”
    Get more information
    Journal Article
  9. 9

    Differential effects of arsenic trioxide on chemosensitization in human hepatic tumor and stellate cell lines by Rangwala, Fatima, Williams, Kevin P, Smith, Ginger R, Thomas, Zainab, Allensworth, Jennifer L, Lyerly, H Kim, Diehl, Anna Mae, Morse, Michael A, Devi, Gayathri R

    Published in BMC cancer (10-09-2012)
    “…Crosstalk between malignant hepatocytes and the surrounding peritumoral stroma is a key modulator of hepatocarcinogenesis and therapeutic resistance. To…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Kupffer cell depletion by CI2MDP-liposomes alters hepatic cytokine expression and delays liver regeneration after partial hepatectomy by Meijer, Catharina, Wiezer, Marinus J., Diehl, Anna M., Yang, Shi-Qi, Schouten, Hylke J., Meijer, Sybren, Van Rooijen, Nico, Van Lambalgen, Antonie A., Dijkstra, Christine D., Van Leeuwen, Paul A. M.

    Published in Liver (Copenhagen) (01-02-2000)
    “…: Background: Although Kupffer cells (KCs) are capable of producing important growth‐stimulating cytokines, their role in liver regeneration following partial…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Nonalcoholic Fatty Liver Disease and the Gut Microbiome by Boursier, Jerome, MD, PhD, Diehl, Anna Mae, MD

    Published in Clinics in liver disease (01-05-2016)
    “…Recent progress has allowed a more comprehensive study of the gut microbiota. Gut microbiota helps in health maintenance and gut dysbiosis associates with…”
    Get full text
    Journal Article
  15. 15

    Hepatic Complications of Obesity by Diehl, Anna Mae, MD

    Published in Gastroenterology clinics of North America (01-03-2010)
    “…Obesity is associated with a spectrum of chronic liver disease. Because obesity increases the risk for advanced forms of liver disease (ie, cirrhosis and liver…”
    Get full text
    Journal Article
  16. 16

    Nonalcoholic Fatty Liver Disease as a Complication of Insulin Resistance by Abdelmalek, Manal F., MD, MPH, Diehl, Anna Mae, MD

    Published in The Medical clinics of North America (01-11-2007)
    “…Nonalcoholic fatty liver disease (NAFLD) refers to a spectrum of liver damage ranging from simple steatosis to nonalcoholic steatohepatitis, advanced fibrosis,…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Apoptosis and Cytokines in Non-Alcoholic Steatohepatitis by Syn, Wing-Kin, MBChB, MRCP, Choi, Steve S., MD, Diehl, Anna Mae, MD

    Published in Clinics in liver disease (01-11-2009)
    “…Non-alcoholic fatty liver disease (NAFLD), one of the commonest causes of chronic liver disease in the United States, represents several overlapping…”
    Get full text
    Journal Article
  19. 19

    Liver Renewal: Detecting Misrepair and Optimizing Regeneration by Machado, Mariana Verdelho, MD, Diehl, Anna Mae, MD

    Published in Mayo Clinic proceedings (2014)
    “…Abstract Cirrhosis and liver cancer, the main causes of liver-related morbidity and mortality, result from defective repair of liver injury. This article…”
    Get full text
    Journal Article
  20. 20